ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
12.70
+0.39 (3.17%)
May 12, 2026, 3:49 PM EDT - Market open
ClearPoint Neuro Market Cap
ClearPoint Neuro has a market cap or net worth of $380.82 million as of May 12, 2026. Its market cap has decreased by -6.25% in one year.
Market Cap
380.82M
Enterprise Value
403.63M
1-Year Change
-6.25%
Ranking
Category
Stock Price
$12.70
Market Cap Chart
Since May 22, 2012, ClearPoint Neuro's market cap has increased from $30.30M to $380.82M, an increase of 1,156.84%. That is a compound annual growth rate of 19.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 365.20M | -6.07% |
| Dec 31, 2025 | 388.80M | -8.37% |
| Dec 31, 2024 | 424.30M | 153.77% |
| Dec 29, 2023 | 167.20M | -19.62% |
| Dec 30, 2022 | 208.00M | -21.57% |
| Dec 31, 2021 | 265.20M | -1.08% |
| Dec 31, 2020 | 268.10M | 267.26% |
| Dec 31, 2019 | 73.00M | 337.13% |
| Dec 31, 2018 | 16.70M | -41.61% |
| Dec 29, 2017 | 28.60M | 132.52% |
| Dec 30, 2016 | 12.30M | -56.84% |
| Dec 31, 2015 | 28.50M | -41.84% |
| Dec 31, 2014 | 49.00M | -42.22% |
| Dec 31, 2013 | 84.80M | 10.42% |
| Dec 31, 2012 | 76.80M | 153.47% |
| May 22, 2012 | 30.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perspective Therapeutics | 442.39M |
| OrthoPediatrics | 441.27M |
| Beta Bionics | 438.93M |
| Pacific Biosciences of California | 420.87M |
| Varex Imaging | 409.03M |
| Standard BioTools | 386.46M |
| Delcath Systems | 381.81M |
| CapsoVision | 362.41M |